Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center and Kyleigh LiPira, CEO of the Melanoma Research F

Jun 3, 2022 · 9m 15s
Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center and Kyleigh LiPira, CEO of the Melanoma Research F
Description

Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients...

show more
Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients facing advanced melanoma. Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center, and Kyleigh LiPira, Melanoma Research Foundation, First-of-its-Kind Dual immunotherapy treatment for advanced melanoma patients talk about a new treatment option and what it may mean for patients facing the disease.
show less
Information
Author BizTalkPodcasts
Organization BizTalkPodcasts
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search